Exaggerated arthropod assault: Eosinophilic dermatosis in a patient with small lymphocytic lymphoma

por Lachowiez, Curtis, White, Kevin, Spurgeon, Stephen
Publicado 2018

Concurrent Presentation of Hodgkin Lymphoma and Multiple Myeloma

por Chandran, Rekha, Simon, Miklos, Spurgeon, Stephen E.
Publicado 2013

Obinutuzumab is Effective in Chronic Lymphocytic Leukemia and Rheumatoid Arthritis After Rituximab Failure: A Case Report

por Lachowiez, Curtis, Deodhar, Atul, Kozin, Eliana, Spurgeon, Stephen
Publicado 2017

Acute promyelocytic leukemia with JAK2 V617F and severe differentiation syndrome

por Braun, Theodore P., Maxson, Julia E., Agarwal, Anupriya, Dunlap, Jennifer, Spurgeon, Stephen E., Traer, Elie
Publicado 2014

A phase Ib, open label, dose escalation trial of the anti-CD37 monoclonal antibody, BI 836826, in combination with ibrutinib in patients with relapsed/refractory chronic lymphocyti...

por Danilov, Alexey V., Spurgeon, Stephen E., Siddiqi, Tanya, Quinson, Anne-Marie, Maier, Daniela, Smith, Dionne, Brown, Jennifer R.
Publicado 2021

Cyclin-Dependent Kinase Inhibitor P1446A Induces Apoptosis in a JNK/p38 MAPK-Dependent Manner in Chronic Lymphocytic Leukemia B-Cells

por Paiva, Cody, Godbersen, J. Claire, Soderquist, Ryan S., Rowland, Taylor, Kilmarx, Sumner, Spurgeon, Stephen E., Brown, Jennifer R., Srinivasa, Sreesha P., Danilov, Alexey V.
Publicado 2015

Small molecule inhibitor screen identifies synergistic activity of the bromodomain inhibitor CPI203 and bortezomib in drug resistant myeloma

por Siegel, Matthew B., Liu, Selina Qiuying, Davare, Monika A., Spurgeon, Stephen E., Loriaux, Marc M., Druker, Brian J., Scott, Emma C., Tyner, Jeffrey W.
Publicado 2015

Entospletinib and obinutuzumab in patients with relapsed/refractory chronic lymphocytic leukemia and B-cell malignancies

por Kittai, Adam S., Best, Scott, Thurlow, Bria, Lam, Vi, Hashiguchi, Taylor, Goodyear, Shaun, Persky, Daniel O., Okada, Craig, Park, Byung, Spurgeon, Stephen E., Danilov, Alexey V.
Publicado 2021

SYK inhibition thwarts the BAFF - B-cell receptor crosstalk and thereby antagonizes Mcl-1 in chronic lymphocytic leukemia

por Paiva, Cody, Rowland, Taylor A., Sreekantham, Bhargava, Godbersen, Claire, Best, Scott R., Kaur, Prabhjot, Loriaux, Marc M., Spurgeon, Stephen E.F., Danilova, Olga V., Danilov, Alexey V.
Publicado 2017

A potential therapeutic strategy for chronic lymphocytic leukemia by combining Idelalisib and GS-9973, a novel spleen tyrosine kinase (Syk) inhibitor

por Burke, Russell T, Meadows, Sarah, Loriaux, Marc M, Currie, Kevin S., Mitchell, Scott A., Maciejewski, Patricia, Clarke, Astrid S., Dipaolo, Julie A., Druker, Brian J., Lannutti, Brian J., Spurgeon, Stephen E.
Publicado 2014

Immunogenicity of Pfizer mRNA COVID-19 vaccination followed by J&J adenovirus COVID-19 vaccination in two CLL patients

por Lyski, Zoe L., Kim, Sunny, Lee, David Xthona, Sampson, David, Raué, Hans P., Raghunathan, Vikram, Ryan, Debbie, Brunton, Amanda E., Slifka, Mark K., Messer, William B., Spurgeon, Stephen E.
Publicado 2021

Immunogenicity of Pfizer mRNA COVID-19 Vaccination Followed by J&J Adenovirus COVID-19 Vaccination in Two Patients with Chronic Lymphocytic Leukemia

por Lyski, Zoe L., Kim, Myung Sun, Xthona Lee, David, Sampson, David, Raué, Hans-Peter, Raghunathan, Vikram, Ryan, Debbie, Brunton, Amanda E., Slifka, Mark K., Messer, William B., Spurgeon, Stephen E.
Publicado 2022

P1200: ZILOVERTAMAB VEDOTIN (MK-2140) IN RELAPSED OR REFRACTORY (R/R) NON-HODGKIN LYMPHOMA (NHL): UPDATED RESULTS FROM THE PHASE 1 WAVELINE-001 STUDY

por Spurgeon, Stephen, Mei, Matthew, Barr, Paul M., Barrientos, Jacqueline, de Vos, Sven, Furman, Richard, Patel, Krish, Thompson, Philip, Choi, Michael Y., Kallam, Avyakta, Wang, Siruo, Ogbu, Uzor, Marinello, Patricia, Wang, Michael
Publicado 2023

Cellular and humoral immune response to mRNA COVID-19 vaccination in subjects with chronic lymphocytic leukemia

por Lyski, Zoe L., Kim, Myung S., Xthona Lee, David, Raué, Hans-Peter, Raghunathan, Vikram, Griffin, Janet, Ryan, Debbie, Brunton, Amanda E., Curlin, Marcel E., Slifka, Mark K., Messer, William B., Spurgeon, Stephen E.
Publicado 2022

Phase 1/2 study of PRO1160, a CD70-directed antibody-drug conjugate, in patients with advanced solid tumors and hematologic malignancies

por Jonasch, Eric, Call, Justin, Kambhampati, Swetha, Caimi, Paolo, Curti, Brendan, Diefenbach, Catherine, Heath, Elisabeth, Park, Steven, Kornblum, Noah, Li, Weidong, Reimers, Melissa, Spurgeon, Stephen, Vaishampayan, Ulka, Ye, Dingwei, Zhang, Li, Zhao, Weili, Chen, Zhu, Hunder, Naomi, Ma, Sharon, Song, Eric, Garmezy, Benjamin
Publicado 2023

Targeting of colony-stimulating factor 1 receptor (CSF1R) in the CLL microenvironment yields antineoplastic activity in primary patient samples

por Edwards V, David K., Sweeney, David Tyler, Ho, Hibery, Eide, Christopher A., Rofelty, Angela, Agarwal, Anupriya, Liu, Selina Qiuying, Danilov, Alexey V., Lee, Patrice, Chantry, David, McWeeney, Shannon K., Druker, Brian J., Tyner, Jeffrey W., Spurgeon, Stephen E., Loriaux, Marc M.
Publicado 2018

Pevonedistat, a Nedd8-activating enzyme inhibitor, in combination with ibrutinib in patients with relapsed/refractory B-cell non-Hodgkin lymphoma

por Torka, Pallawi, Kambhampati, Swetha, Chen, Lu, Wang, Xiaoguang, Chen, Canping, Vuong, Dan, Qin, Hanjun, Muir, Alexandra, Orand, Kirsten, Borja, Ivana, Lynne Smith, D., Herrera, Alex F., Spurgeon, Stephen E. F., Park, Byung, Lewis, Lionel D., Hernandez-Ilizaliturri, Francisco, Xia, Zheng, Danilov, Alexey V.
Publicado 2023

Phase 1b study of tirabrutinib in combination with idelalisib or entospletinib in previously treated B-cell lymphoma

por Morschhauser, Franck, Dyer, Martin J. S., Walter, Harriet S., Danilov, Alexey V., Ysebaert, Loic, Hodson, Daniel James, Fegan, Christopher, Rule, Simon A., Radford, John, Cartron, Guillaume, Bouabdallah, Krimo, Davies, Andrew John, Spurgeon, Stephen, Rajakumaraswamy, Nishanthan, Li, Biao, Humeniuk, Rita, Huang, Xi, Bhargava, Pankaj, Jürgensmeier, Juliane M., Salles, Gilles
Publicado 2020

Combined epigenetic and immunotherapy for blastic and classical mantle cell lymphoma

por LeBlanc, Francis R., Hasanali, Zainul S., Stuart, August, Shimko, Sara, Sharma, Kamal, Leshchenko, Violetta V., Parekh, Samir, Fu, Haiqing, Zhang, Ya, Martin, Melvenia M., Kester, Mark, Fox, Todd, Liao, Jiangang, Loughran, Thomas P., Evans, Juanita, Pu, Jeffrey J., Spurgeon, Stephen E., Aladjem, Mirit I., Epner, Elliot M.
Publicado 2022

Diminished humoral and cellular responses to SARS-CoV-2 vaccines in patients with chronic lymphocytic leukemia

por Ujjani, Chaitra, Gooley, Ted A., Spurgeon, Stephen E., Stephens, Deborah M., Lai, Catherine, Broome, Catherine M., O’Brien, Susan, Zhu, Haiying, Laing, Kerry J., Winter, Allison M., Pongas, Georgios, Greninger, Alexander L, Koelle, David M., Siddiqi, Tanya, Davids, Matthew S., Rogers, Kerry A., Danilov, Alexey V., Sperling, Amy, Tu, Brian, Sorensen, Tyler, Launchbury, Kelsey, Burrow, Carlissa J., Quezada, Genesis, Hill, Joshua A., Shadman, Mazyar, Thompson, Philip A.
Publicado 2022